Absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis.

To unravel the conflicting data concerning the dependence of human cholesterol biosynthesis on functional peroxisomes, we determined activities and levels of selected enzymes involved in cholesterol biosynthesis in livers of PEX5 knockout mice, a well-characterized model for human Zellweger syndrome. We found that all enzymes measured, including putative peroxisomal enzymes, are at least as active in the peroxisome-deficient Zellweger mice as in control mice, indicating that mislocalization of enzymes to the cytosol does not lead to decreased activity or degradation. Prompted by these results, we re-examined this aspect in human subjects by specific enzyme activity measurements and immunoblotting with highly specific antisera. Our results show that the previously reported deficiencies of mevalonate kinase and phosphomevalonate kinase activity in livers from human Zellweger patients reflect the bad condition of the livers, rather than mislocalization to the cytosol. Our data provide an explanation for the conflicting findings in the literature and show that great care should be taken in the interpretation of data obtained in postmortem material.

[1]  A. Honda,et al.  Accurate detection of Smith–Lemli–Opitz syndrome carriers by measurement of the rate of reduction of the ergosterol C-7 double bond in cultured skin fibroblasts , 1998, Journal of Inherited Metabolic Disease.

[2]  R. Wanders,et al.  Infantile Refsum disease: an inherited peroxisomal disorder , 1987, European Journal of Pediatrics.

[3]  I. Vanhorebeek,et al.  Isoprenoid biosynthesis is not compromised in a Zellweger syndrome mouse model , 2001 .

[4]  S. Krisans,et al.  Peroxisomal protein targeting and identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes. , 2000, Biochimica et biophysica acta.

[5]  D. Valle,et al.  Peroxisome biogenesis disorders: genetics and cell biology. , 2000, Trends in genetics : TIG.

[6]  R. Hennekam,et al.  The Smith-Lemli-Opitz syndrome , 2000, Journal of Medical Genetics.

[7]  T. Tansey,et al.  Differential binding of proteins to peroxisomes in rat hepatoma cells: unique association of enzymes involved in isoprenoid metabolism. , 1999, Journal of lipid research.

[8]  L. Hagenfeldt,et al.  Synthesis of Mevalonate Pathway Lipids in Fibroblasts from Zellweger and X-linked ALD Patients , 1999, Pediatric Research.

[9]  H. Waterham,et al.  Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis. , 1999, Human molecular genetics.

[10]  K. Gibson,et al.  Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting. , 1999, Journal of lipid research.

[11]  R. Wanders,et al.  Differential deficiency of mevalonate kinase and phosphomevalonate kinase in patients with distinct defects in peroxisome biogenesis: evidence for a major role of peroxisomes in cholesterol biosynthesis. , 1998, Biochemical and biophysical research communications.

[12]  Robert V Farese,et al.  Cholesterol metabolism and embryogenesis. , 1998, Trends in genetics : TIG.

[13]  T. Tsukamoto,et al.  Peroxisome Targeting Signal Type 1 (PTS1) Receptor Is Involved in Import of Both PTS1 and PTS2: Studies withPEX5-Defective CHO Cell Mutants , 1998, Molecular and Cellular Biology.

[14]  P. Carmeliet,et al.  A mouse model for Zellweger syndrome , 1997, Nature Genetics.

[15]  S. Krisans,et al.  Cloning and Subcellular Localization of Hamster and Rat Isopentenyl Diphosphate Dimethylallyl Diphosphate Isomerase , 1997, The Journal of Biological Chemistry.

[16]  H. Tabak,et al.  Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor , 1997, Nature Genetics.

[17]  S. Subramani Protein Translocation into Peroxisomes* , 1996, The Journal of Biological Chemistry.

[18]  I. Singh,et al.  Abnormality in Translational Regulation of Catalase Expression in Disorders of Peroxisomal Biogenesis , 1996, Journal of neurochemistry.

[19]  S. Krisans,et al.  Compartmentalization of Cholesterol Biosynthesis , 1996, The Journal of Biological Chemistry.

[20]  R. Wanders,et al.  Peroxisomal disorders: a review. , 1995, Journal of neuropathology and experimental neurology.

[21]  H. Mandel,et al.  Reduced cellular cholesterol content in peroxisome-deficient fibroblasts is associated with impaired uptake of the patient's low density lipoprotein and with reduced cholesterol synthesis. , 1995, Journal of lipid research.

[22]  G. Kostner,et al.  Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin , 1995, European journal of clinical investigation.

[23]  R. Wanders,et al.  Purification of peroxisomal acyl-CoA: dihydroxyacetonephosphate acyltransferase from human placenta. , 1994, Biochimica et biophysica acta.

[24]  P. Edwards,et al.  Farnesyl-diphosphate synthase is localized in peroxisomes. , 1994, The Journal of biological chemistry.

[25]  G A Keller,et al.  Mevalonate kinase is predominantly localized in peroxisomes and is defective in patients with peroxisome deficiency disorders. , 1994, The Journal of biological chemistry.

[26]  B. Neel,et al.  Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. , 1993, Analytical biochemistry.

[27]  S. Subramani,et al.  Protein import into peroxisomes and biogenesis of the organelle. , 1993, Annual review of cell biology.

[28]  Victoria J. Hodge,et al.  Normal cholesterol synthesis in human cells requires functional peroxisomes. , 1991, Biochemical and biophysical research communications.

[29]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[30]  R. Wanders,et al.  Age-related accumulation of phytanic acid in plasma from patients with the cerebro-hepato-renal (Zellweger) syndrome. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[31]  R. Wanders,et al.  Peroxisomal beta-oxidation of palmitoyl-CoA in human liver homogenates and its deficiency in the cerebro-hepato-renal (Zellweger) syndrome. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[32]  S. Singer,et al.  3-Hydroxy-3-methylglutaryl-coenzyme A reductase is present in peroxisomes in normal rat liver cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Kyhse-Andersen Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. , 1984, Journal of biochemical and biophysical methods.

[34]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[35]  M. Brown,et al.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[36]  W. Cleland,et al.  Purification and mechanism of action of hog liver mevalonic kinase. , 1970, The Journal of biological chemistry.